Children's compound ephedrine platycodon syrup

The ammonium chloride in this product can reflexively increase the secretion of respiratory mucosal glands, thereby making it easier to discharge sputum and facilitating the removal of sticky sputum; ephedrine hydrochloride can relax bronchial smooth muscles, contract bronchial mucosal blood vessels, reduce congestion and edema, and improve airway obstruction; Platycodon grandiflorum fluid extract contains platycodon saponins, which can increase respiratory mucus secretion, dilute sputum, and make it easier to cough up; Polygala tenuifolia fluid extract and Aster tataricus fluid extract have the same effect as Platycodon grandiflorum fluid extract

This product is a compound preparation, and its components are: 0.8mg of ephedrine hydrochloride, 30mg of platycodon, 15mg of ammonium chloride, 0.3mg of phenobarbital, 15mg of sodium citrate, 2mg of citric acid, 0.15mg of menthol, 1.5mg of benzoic acid, 0.004ml of anise water, and 0.002ml of chloroform per 1ml

Used for cough and sputum caused by children's colds and bronchitis.

Oral administration. 3 to 4 times a day. 5 to 15 years old: 5 to 15 ml each time; 2 to 5 years old: 3 to 4 ml each time; for children under 2 years old, reduce the dosage accordingly.

1. Occasionally, there may be palpitations, fever, sweating, etc., which will disappear after a short rest. 2. Large doses or long-term use may cause mental excitement, tremors, anxiety, insomnia, heartache, palpitations, tachycardia, etc. 3. It may cause subtle emotional changes and cognitive and memory defects. 4. Long-term use may occasionally cause folic acid deficiency and hypocalcemia. 5. Rare megaloblastic anemia and osteomalacia. 6. Large doses may produce nystagmus, ataxia and severe respiratory depression. 7. About 1% to 3% of patients using this product have skin reactions, most commonly various rashes, severe cases may develop exfoliative dermatitis and erythema multiforme (or Stevens-Johnson syndrome), and toxic epidermal necrosis is extremely rare. 8. There are reports of hepatitis and liver dysfunction in users. 9. Long-term use may lead to drug dependence, and withdrawal syndrome is prone to occur after stopping the drug.

1. This product is contraindicated for patients who are allergic to it. 2. This product is contraindicated for patients with liver and kidney dysfunction. 3. This product is contraindicated for patients with hypertension, arteriosclerosis, and angina pectoris. 4. This product is contraindicated for patients with hyperthyroidism.

1. Ephedrine is incompatible with sulfadiazine, nitrofurantoin, etc. 2. Ephedrine combined with adrenal cortical hormones can increase the latter's metabolic clearance rate, and the dose of corticosteroids needs to be adjusted. 3. Urine alkalinizing agents such as antacids, calcium and magnesium carbonates, citrates, sodium bicarbonate, etc. can affect the excretion of ephedrine hydrochloride in urine, increase the half-life of ephedrine hydrochloride, and prolong the duration of action. 4. Ephedrine should not be used in combination with pargyline monoamine oxidase inhibitors to avoid causing high blood pressure. 5. Ephedrine combined with digitalis glycosides can cause arrhythmias. 6. Ephedrine combined with ergonovine, ergotamine or oxytocin can aggravate vasoconstriction, leading to severe hypertension or peripheral tissue ischemia.

Sealed and stored in a cool place.

Compound

China Aoxing Pharmaceutical Company

• Founded in:

  2002-01-20

• Address:

  No. 1, Nanhuan East Road, Xinle City, Shijiazhuang, Hebei Province

• Tax NO.:

  9113010010791788XK

• Registered Funds:

  70 million yuan

• Website:

  Log in to view

• Email:

  Log in to view